During the past decade, Leopoldina Krankenhaus conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leopoldina Krankenhaus" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "AGO Research GmbH" with 2 trials sponsored, "AGO Study Group" with 1 trials sponsored and "AIO-Studien-gGmbH" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leopoldina Krankenhaus" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator and "AGO-B" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Leopoldina Krankenhaus" are "Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Adenocarcinoma" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Leopoldina Krankenhaus" in a lesser frequency.

Most popular intervention types in "Leopoldina Krankenhaus" are "Drug" (23 trials), "Biological" (7 trials), "Radiation" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "radiation therapy" (5 trials), "vincristine sulfate" (5 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "Leopoldina Krankenhaus" are 20 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Leopoldina Krankenhaus". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Leopoldina Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Leopoldina Krankenhaus, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".